Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis
about
The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-cateninCancer metabolism and elevated O-GlcNAc in oncogenic signalingFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyE-cadherin roles in animal biology: A perspective on thyroid hormone-influenceRBEL1 is a novel gene that encodes a nucleocytoplasmic Ras superfamily GTP-binding protein and is overexpressed in breast cancerA new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugs.O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressElevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytesBcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated BaxAberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.N-glycosylation regulates ADAM8 processing and activationCross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome.Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expressionAkt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.Posttranslational truncation of E-cadherin and significance for tumour progression.Secretion of N- and O-linked Glycoproteins from 4T1 Murine Mammary Carcinoma CellsModulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells.Interactome disassembly during apoptosis occurs independent of caspase cleavage.Potential roles of N-glycosylation in cell adhesion.E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions.The role of intracellular protein O-glycosylation in cell adhesion and disease.The potential role of O-GlcNAc modification in cancer epigenetics.The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene ExpressionN-glycosylation affects the molecular organization and stability of E-cadherin junctions.Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial CellsUDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression.EMT and tumor metastasisCellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome.Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer.Multiple post-translational modifications regulate E-cadherin transport during apoptosis.Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients.Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.O-GlcNAcylation in women's cancers: breast, endometrial and ovarian.
P2860
Q24610351-56379621-4CB7-4EE0-B4A9-A7E74491EB09Q26859087-27E28D66-0AEE-4FB5-B430-3EFDF9AA14A7Q27009399-740963F0-D7AD-4509-AB42-AD91D3AC7DA6Q28079585-82591CE4-0A63-471C-B06C-070FF71E73ECQ28118832-DBD0E34F-C7BA-455E-A34B-7786B2C3292DQ30465306-330B7681-D69F-4321-9B5F-D49DA8BC35F2Q33433251-8009405A-E876-4D63-B99E-56B2928779A2Q33625265-EBE4ACA7-67CA-40D6-9333-6A9FDA308394Q34024499-BCC2CF6F-CBA0-4A98-AE42-C45F450B1992Q34312445-958F93D9-9504-472E-8C0B-08944356027BQ34488445-F26B76A4-9995-4865-BC64-2E0AB75BF0BCQ34580432-BDE02DA1-A87B-4A5A-988B-9EF379BD9EB4Q35804446-C0A1F171-D273-49E8-BCDD-7A87CD89B6DCQ36033212-A874AB6C-6AB7-4C59-83C9-86591BD8B2F0Q36217277-547BCFC5-9455-432E-ABD0-8CBA4F636C1AQ36533355-C993C2F3-DCD6-4721-A74E-CFD02613F935Q36803798-670BB7E9-1E67-4FD7-9965-3093FFEE4454Q36857851-C97CA2F7-51AC-496B-8876-292B06E4137BQ36934474-96E8545A-99D9-43AA-B4D7-AA4248B42075Q37526182-AF4F4E19-1A76-4951-8288-98F3A84CA661Q37626307-9A90921C-2966-4C54-8903-9C4F626CA475Q38008222-67F629D0-908E-4225-B92D-BDC073E65BA5Q38030236-E0740BB2-83B2-4D29-9432-F1590532D2DEQ38095924-C5FF22B5-3A8B-487F-AC17-EAD9C37E9840Q38241688-19220721-816A-4093-BA6C-F95C4E033A3CQ38284902-25A0EBBC-F33B-4E4F-977B-B29B3CB28F94Q38313509-058B7835-B152-4C10-AAA8-76AC324CF31AQ38703282-E32A325C-B013-4386-91F6-A53C5C26AB2BQ38774503-45C3611A-5011-413E-961A-62CDE2B35309Q38793692-7850065F-7592-4B9C-B6DC-83754718A0A0Q39216425-711370CA-AE05-4512-9FCE-9E0D51130FFFQ39443781-1572740D-9EA6-4856-957C-99B90CAD8034Q39482700-B253232D-8D1D-451C-AD4F-0F8D701EF90DQ40271663-37D98BB2-7913-4E5C-8935-85003D191F76Q40626766-04A94FF3-956A-4F10-9F64-D83CA3A92D5CQ42241744-B9B44E61-4823-42F4-BDE0-65AC9DE68E5CQ43100373-F0244D70-1F20-4A4B-A55B-90DF3253EFC7Q44570228-B7D3D4E9-3449-4150-8FE9-AB64BC90F9DDQ47324885-B95A2D95-DDC4-4B16-9796-B0B259A95367Q47414275-E291866F-DC20-4130-8246-F765F7184FE4
P2860
Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@ast
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@en
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@nl
type
label
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@ast
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@en
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@nl
prefLabel
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@ast
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@en
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@nl
P2860
P356
P1433
P1476
Cytoplasmic O-glycosylation pr ...... of E-cadherin during apoptosis
@en
P2860
P304
P356
10.1093/EMBOJ/20.21.5999
P407
P577
2001-11-01T00:00:00Z